Phio Pharmaceuticals - Warrants (21/12/2021) (PHIOW) has a P/B ratio of 0.02, below the Healthcare sector average of 6.23.
Get informed when a big investor buys or sells
+ Follow0.02
The Price-to-Book ratio compares a company's market value to its book value. A lower P/B ratio may suggest that the stock is undervalued relative to its assets.
As of the most recent data, PHIOW shows a P/B ratio of 0.02. That is below the Healthcare sector average of 6.23. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/B ratio is about 6.23. Phio Pharmaceuticals - Warrants (21/12/2021) is at 0.02, which is lower that average. That is roughly 99.6% below the sector mean. Use the comparison chart on this page to see how PHIOW stacks up against individual peers as well.
Investors watch PHIOW's P/B ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Phio Pharmaceuticals - Warrants (21/12/2021)'s latest reading is 0.02. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this price-to-book ratio page, Stockcircle has Phio Pharmaceuticals - Warrants (21/12/2021)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/B ratio (currently 0.02) with ownership activity and broader fundamentals.
The Healthcare average P/B ratio is about 6.23, while PHIOW is at 0.02. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.